Showing results (271-280 of 592) with videos related to

Sort By:
Pageof 60
Mediators of Inflammation|December 13, 2019
Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung CancerCarmine Carbone, Geny Piro, Vincenzo Di Noia, et al.
Reviews on Recent Clinical Trials|May 20, 2022
Is Surgery Worthwhile in Locally-advanced NSCLC Patients with Persistent N2-disease After Neoadjuvant Therapy?Filippo Lococo, Marco Chiappetta, Corolina Sassorossi, et al.
Frontiers in Oncology|April 27, 2019
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival MelanomaErnesto Rossi, Brigida Anna Maiorano, Monica Maria Pagliara, et al.
Cancers|April 3, 2021
Survival Analysis in Single N2 Station Lung Adenocarcinoma: The Prognostic Role of Involved Lymph Nodes and Adjuvant TherapyMarco Chiappetta, Filippo Lococo, Giovanni Leuzzi, et al.
Stem Cells (Dayton, Ohio)|November 28, 2014
Mesenchymal progenitors aging highlights a miR-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesisOlivia Candini, Carlotta Spano, Alba Murgia, et al.
Thoracic Cancer|November 21, 2020
Estimated direct costs of non-small cell lung cancer by stage at diagnosis and disease management phase: A whole-disease modelAlessandra Buja, Michele Rivera, Anna De Polo, et al.
Biochimica Et Biophysica Acta|February 11, 2014
Targeting bone metastatic cancer: Role of the mTOR pathwayFrancesco Bertoldo, Franco Silvestris, Toni Ibrahim, et al.
The New England Journal of Medicine|June 6, 2017
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA MutationMark Robson, Seock-Ah Im, Elżbieta Senkus, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 10, 2020
External validation of the N descriptor in the proposed tumour-node-metastasis subclassification for lung cancer: the crucial role of histological type, number of resected nodes and adjuvant therapyMarco Chiappetta, Filippo Lococo, Giovanni Leuzzi, et al.
World Journal of Gastrointestinal Surgery|October 8, 2021
Neoadjuvant treatment: A window of opportunity for nutritional prehabilitation in patients with pancreatic ductal adenocarcinomaIlaria Trestini, Marco Cintoni, Emanuele Rinninella, et al.
Pageof 60